Roche Aktie
344,00
EUR
-1,40
EUR
-0,41
%
343,45
EUR
-2,50
EUR
-0,72
%
Roche jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Roche Aktie Analyse
| 20.03.18 | Roche overweight | JP Morgan Chase & Co. | |
| 14.03.18 | Roche Sell | Société Générale Group S.A. (SG) | |
| 02.03.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.02.18 | Roche buy | Jefferies & Company Inc. | |
| 20.02.18 | Roche Hold | Kepler Cheuvreux | |
| 20.02.18 | Roche Neutral | UBS AG | |
| 12.02.18 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 06.02.18 | Roche Neutral | UBS AG | |
|
Werbung
|
|||
| 06.02.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.02.18 | Roche overweight | JP Morgan Chase & Co. | |
| 05.02.18 | Roche overweight | Barclays Capital | |
| 05.02.18 | Roche Hold | Deutsche Bank AG | |
| 02.02.18 | Roche overweight | JP Morgan Chase & Co. | |
| 02.02.18 | Roche kaufen | DZ BANK | |
| 02.02.18 | Roche Outperform | Bernstein Research | |
| 01.02.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.01.18 | Roche Hold | Kepler Cheuvreux | |
| 17.01.18 | Roche Hold | Deutsche Bank AG | |
| 15.01.18 | Roche Neutral | UBS AG | |
| 15.01.18 | Roche Hold | Deutsche Bank AG | |
| 15.01.18 | Roche Sell | Société Générale Group S.A. (SG) | |
| 11.01.18 | Roche overweight | JP Morgan Chase & Co. | |
| 08.01.18 | Roche Neutral | UBS AG | |
| 05.01.18 | Roche buy | Jefferies & Company Inc. | |
| 29.12.17 | Roche overweight | JP Morgan Chase & Co. | |
| 27.12.17 | Roche kaufen | Norddeutsche Landesbank (Nord/LB) | |
| 21.12.17 | Roche overweight | Barclays Capital | |
| 13.12.17 | Roche overweight | JP Morgan Chase & Co. | |
| 12.12.17 | Roche Hold | Deutsche Bank AG | |
| 12.12.17 | Roche overweight | JP Morgan Chase & Co. | |
| 11.12.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.12.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.12.17 | Roche Equal-Weight | Morgan Stanley | |
| 08.12.17 | Roche Neutral | UBS AG | |
| 08.12.17 | Roche overweight | JP Morgan Chase & Co. | |
| 07.12.17 | Roche Neutral | UBS AG | |
| 07.12.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.12.17 | Roche Neutral | UBS AG | |
| 06.12.17 | Roche buy | Merrill Lynch & Co., Inc. | |
| 01.12.17 | Roche Equal-Weight | Morgan Stanley | |
| 01.12.17 | Roche Outperform | Bernstein Research | |
| 21.11.17 | Roche buy | Baader Bank | |
| 21.11.17 | Roche Hold | Deutsche Bank AG | |
| 21.11.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.11.17 | Roche Reduce | HSBC | |
| 20.11.17 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.11.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.11.17 | Roche overweight | JP Morgan Chase & Co. | |
| 17.11.17 | Roche Equal-Weight | Morgan Stanley | |
| 17.11.17 | Roche Hold | Deutsche Bank AG | |
Werbung
Werbung